Coronavirus Update - 24th June 2020

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We remain open for business as usual.

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

Bioanalytical Services

We develop, validate and apply assays for small and large molecules, generics, and biomarkers to provide essential exposure data for drug development. Our comprehensive services complement drug discovery and development needs from preclinical development through to market. Our work is provided on both a stand-alone basis and as part of an integrated service offering.

View the Bioanalytical Equipment and Capabilities List